Senseonics Announces Initiation of European Commercial ... | 合法醫療器材資訊網

2021年2月1日—IntheUS,AscensiaisalreadyprovidingsalessupportfortheoriginalEversense​®CGMsystem.AscensiaDiabetesCareisaglobalspecialist ...

Senseonics Announces Initiation of European Commercial Efforts by Partner Ascensia Diabetes Care

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that Ascensia Diabetes Care (Ascensia) has commenced sales and marketing activities for the Eversense® XL CGM system in key European markets as of today, as part of their strategic partnership announced in August, 2020.

“Today, we are extremely excited to see Ascensia, a global leader in the diabetes technology space, begin distribution of the Eversense XL in these key European markets. We are confident our shared goal of bringing our advanced long-term solution to more people with diabetes will be accomplished through Asc...